Bibliographic information
GuidelineTreatment of Tuberculosis: Guidelines
Year of Publication2010
Issuing Institution
Recommendation
Maintained
Originally developed
New patients with pulmonary TB should receive a regimen containing 6 months of rifampicin: 2HRZE/4HR
Recommended in favor
Strong
Certainty of evidence
High
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Year2017
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment.
Year2022
InstitutionWHO
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year2025
InstitutionWorld Health Organization